Marina A Dobrovolskaia

发表

Animal models for analysis of immunological responses to nanomaterials: Challenges and considerations.

William C Zamboni, Janos Szebeni, Serguei V Kozlov, 2018, Advanced drug delivery reviews.

Publisher Correction: On the issue of transparency and reproducibility in nanomedicine

May Azzawi, Steve Conlan, Steve Rannard, 2019, Nature Nanotechnology.

Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge.

Anil K Patri, Marina A Dobrovolskaia, Scott E McNeil, 2012, Nanomedicine.

Detection and quantitative evaluation of endotoxin contamination in nanoparticle formulations by LAL-based assays.

Marina A Dobrovolskaia, M. Dobrovolskaia, Barry W Neun, 2011, Methods in molecular biology.

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Parag Aggarwal, Marina A Dobrovolskaia, Scott E McNeil, 2009, Advanced drug delivery reviews.

Ambiguities in applying traditional Limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations.

Marina A Dobrovolskaia, Scott E McNeil, Julia Ljubimova, 2010, Nanomedicine.

Methods for Analysis of Nanoparticle Immunosuppressive Properties In Vitro and In Vivo.

Marina A Dobrovolskaia, Timothy M Potter, Barry W Neun, 2018, Methods in molecular biology.

Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy.

Marina A Dobrovolskaia, M. Dobrovolskaia, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Toll receptors, CD14, and macrophage activation and deactivation by LPS.

Marina A Dobrovolskaia, M. Dobrovolskaia, S. Vogel, 2002, Microbes and infection.

Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles.

Anil K Patri, Marina A Dobrovolskaia, Scott E McNeil, 2014, Nanomedicine : nanotechnology, biology, and medicine.

Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro

Yechezkel Barenholz, Janos Szebeni, Marina A Dobrovolskaia, 2018, Molecules.

Evaluation of nanoparticle immunotoxicity.

Marina A Dobrovolskaia, M. Dobrovolskaia, D. Germolec, 2009, Nature nanotechnology.

Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.

Parag Aggarwal, Anil K Patri, Marina A Dobrovolskaia, 2009, Nanomedicine : nanotechnology, biology, and medicine.

Nanoparticles and the blood coagulation system. Part II: safety concerns.

Marina A Dobrovolskaia, M. Dobrovolskaia, A. Ilinskaya, 2013, Nanomedicine.

Choice of method for endotoxin detection depends on nanoformulation.

Marina A Dobrovolskaia, Scott E McNeil, Jennifer H. Grossman, 2014, Nanomedicine.

Nanoparticles and the immune system.

Marina A Dobrovolskaia, Nakissa Sadrieh, Á. González-Fernández, 2010, Endocrinology.

Quantitative characterization of quantum dot‐labeled lambda phage for Escherichia coli detection

Jeeseong Hwang, Marina A Dobrovolskaia, Peter B. Yim, 2009, Biotechnology and bioengineering.

Current understanding of interactions between nanoparticles and the immune system.

Marina A Dobrovolskaia, Anna A Shvedova, M. Dobrovolskaia, 2016, Toxicology and applied pharmacology.

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.

Dan Peer, Biana Godin, Ji-Ho Park, 2017, ACS nano.

Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.

Marina A Dobrovolskaia, Scott E McNeil, M. Dobrovolskaia, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.

Marina A Dobrovolskaia, M. Dobrovolskaia, A. Ilinskaya, 2013, Nanomedicine.

Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.

Anil K Patri, Marina A Dobrovolskaia, Scott E McNeil, 2012, Molecular pharmaceutics.

Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Marina A Dobrovolskaia, M. Dobrovolskaia, Ankit Shah, 2018, Nanomedicine : nanotechnology, biology, and medicine.

Method for analysis of nanoparticle hemolytic properties in vitro.

Anil K Patri, Marina A Dobrovolskaia, Scott E McNeil, 2008, Nano letters.